Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy



Status:Archived
Conditions:High Cholesterol, Diabetes
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2010
End Date:October 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study to Assess the LDL Cholesterol Lowering and Anti-Hyperglycemic Efficacy of Welchol® (Colesevelam) in Subjects With Impaired Fasting Glucose Who Are Taking Niaspan® (Niacin) for Dyslipidemia


The present study will assess the low-density lipoprotein cholesterol (LDL-C) lowering
effect of colesevelam as an adjunct to niacin for the improvement of lipids and glycemic
control in dyslipidemic subjects with impaired fasting glucose.



We found this trial at
4
sites
Hematology Oncology Associates of the Quad Cities
1351 Kimberly Rd
Bettendorf, Iowa 52722
(563) 355-7733
Hematology Oncology Associates of the Quad Cities
?
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Radiant Research Inc.
Chicago, Illinois 60654
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Clinical Trial Facility
Kansas City, Kansas
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
Clinical Trial Facility
St Louis, Missouri
?
mi
from
St Louis, MO
Click here to add this to my saved trials